Christina L Fanola
Overview
Explore the profile of Christina L Fanola including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
773
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Isselbacher E, Preventza O, Hamilton Black 3rd J, Augoustides J, Beck A, Bolen M, et al.
J Thorac Cardiovasc Surg
. 2023 Jun;
166(5):e182-e331.
PMID: 37389507
Aim: The "2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease" provides recommendations to guide clinicians in the diagnosis, genetic evaluation and family screening, medical therapy, endovascular and...
2.
Isselbacher E, Preventza O, Hamilton Black Iii J, Augoustides J, Beck A, Bolen M, et al.
J Am Coll Cardiol
. 2022 Nov;
80(24):e223-e393.
PMID: 36334952
Aim: The "2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease" provides recommendations to guide clinicians in the diagnosis, genetic evaluation and family screening, medical therapy, endovascular and...
3.
Isselbacher E, Preventza O, Hamilton Black 3rd J, Augoustides J, Beck A, Bolen M, et al.
Circulation
. 2022 Nov;
146(24):e334-e482.
PMID: 36322642
Aim: The "2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease" provides recommendations to guide clinicians in the diagnosis, genetic evaluation and family screening, medical therapy, endovascular and...
4.
Fanola C, Norby F, Shah A, Chang P, Lutsey P, Rosamond W, et al.
J Am Coll Cardiol
. 2020 Jan;
75(2):148-158.
PMID: 31948643
Background: Heart failure (HF) hospitalization places patients at increased short-term risk for venous thromboembolism (VTE). Long-term risk for VTE associated with incident HF, HF subtypes, or structural heart disease is ...
5.
Faizer R, Weinhandl E, El Hag S, Le Jeune S, Apostolidou I, Shafii S, et al.
J Vasc Surg
. 2019 Jan;
70(1):92-101.e1.
PMID: 30611580
Background: Endovascular aneurysm repair (EVAR) is an accepted approach for patients presenting with ruptured abdominal aortic aneurysm (rAAA) and suitable anatomy. The effect of anesthesia modality on mortality outcomes in...
6.
Aday A, Kreykes S, Fanola C
Curr Treat Options Cardiovasc Med
. 2018 Nov;
20(12):103.
PMID: 30421267
Purpose Of Review: Numerous studies have begun to unravel the genetic basis of not only aortic disease but also other forms of commonly encountered vascular diseases. The goal of this...
7.
Fanola C, Ruff C, Murphy S, Jin J, Duggal A, Babilonia N, et al.
J Am Heart Assoc
. 2018 Oct;
7(16):e008987.
PMID: 30369307
Background Anticoagulation in patients with malignancy and atrial fibrillation is challenging because of enhanced risks for thrombosis and bleeding and the frequent need for invasive procedures. Data on direct oral...
8.
Bohula E, Wiviott S, McGuire D, Inzucchi S, Kuder J, Im K, et al.
N Engl J Med
. 2018 Aug;
379(12):1107-1117.
PMID: 30145941
Background: Lorcaserin, a selective serotonin 2C receptor agonist that modulates appetite, has proven efficacy for weight management in overweight or obese patients. The cardiovascular safety and efficacy of lorcaserin are...
9.
Perez Cabeza A, Bravo Marques R, Chinchurreta Capote P, Ruiz Mateas F, Fanola C, Rosas Cervantes G, et al.
Clin Cardiol
. 2018 Aug;
41(9):1252-1258.
PMID: 30062699
Background: The TIMI-AF score predicts poor outcomes in patients with atrial fibrillation (AF) and guides selection of anticoagulant therapy by identifying clinical benefit of direct oral anticoagulants (DOACs) or vitamin...
10.
Bergmark B, Scirica B, Steg P, Fanola C, Gurmu Y, Mosenzon O, et al.
Eur Heart J
. 2018 Feb;
39(24):2255-2262.
PMID: 29394350
Aims: Optimal blood pressure for prevention of cardiovascular (CV) events in patients with Type 2 diabetes mellitus (T2DM) remains uncertain and there is concern for increased risk with low diastolic...